Vanda Pharmaceuticals (VNDA) Tax Rate Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,181.00 |
| Dec 31, 2025 | -30,026.00 |
| Sep 30, 2025 | -1,986.00 |
| Jun 30, 2025 | -959.00 |
| Mar 31, 2025 | 608.00 |
| Dec 31, 2024 | 716.00 |
| Sep 30, 2024 | -1,311.00 |
| Jun 30, 2024 | -532.00 |
| Mar 31, 2024 | -633.00 |
| Dec 31, 2023 | -6,883.00 |
| Sep 30, 2023 | 18,496.00 |
| Jun 30, 2023 | 2,080.00 |
| Mar 31, 2023 | -1,923.00 |
| Dec 31, 2022 | 152.00 |
| Sep 30, 2022 | 75,833.00 |
| Jun 30, 2022 | 3,151.00 |
| Mar 31, 2022 | 1,665.00 |
| Dec 31, 2021 | 1,839.00 |
| Sep 30, 2021 | 2,615.00 |
| Jun 30, 2021 | 2,150.00 |
| Mar 31, 2021 | 1,712.00 |
| Dec 31, 2020 | 2,985.00 |
| Sep 30, 2020 | 2,972.00 |
| Jun 30, 2020 | 2,210.00 |
| Mar 31, 2020 | 6,109.00 |